Sleep aid trazodone may pose hidden danger for seniors with weak kidneys
NCT ID NCT07381101
First seen Feb 02, 2026 · Last updated May 03, 2026 · Updated 13 times
Summary
This study examined over 31,000 older adults (65+) with chronic kidney disease to see if starting a higher dose of the sleep medication trazodone (75-150 mg/day) increases the risk of hospitalization, emergency visits, or death within 30 days compared to a lower dose (25-75 mg/day). The goal was to understand medication safety in this vulnerable group, not to test a new treatment. Results will help guide safer prescribing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OLDER ADULTS (65 YEARS AND OLDER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
London Health Sciences Centre Research Institute
London, Ontario, Canada
Conditions
Explore the condition pages connected to this study.